Protagenic Therapeutics, Inc.new (PTIX) Ending Cash Balance (2009 - 2026)
Protagenic Therapeutics, Inc.new's Ending Cash Balance came in at $76,909 for fiscal Q2 2027 (quarter ended Sep 30, 2026), down 97.2% from $2.72 million a year earlier and down 86.4% from the prior quarter.
Protagenic Therapeutics, Inc.new (PTIX) Ending Cash Balance (2009 - 2026) Analysis & Trends
For FY2026 (ended Mar 31, 2026), Protagenic Therapeutics, Inc.new's Ending Cash Balance was $1.51 million.
- Ending Cash Balance carries a five-year compound annual growth rate of 22.8% (FY2021 to FY2026).
- Going back by fiscal year, Ending Cash Balance was $14,531 in FY2025, $79,568 in FY2024 (-93.8%), $1.29 million in FY2023 (+498.5%) and $215,189 in FY2022 (-60.2%).
- The fiscal Q2 2027 figure represents the lowest quarterly Ending Cash Balance since fiscal Q4 2025.
- Business Quant data shows PTIX's Ending Cash Balance at $565,985 (Q1 2027), $1.51 million (Q4 2026) and $2.21 million (Q3 2026) in the three fiscal quarters before Q2 2027.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Ending Cash Balance (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | 9.65 Bn |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | 1.88 Bn |
| 10 | Protagenic Therapeutics, Inc.new | 850,797.76 | -4.70 Mn | - | 76,909.00 |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 76,909.00 |
| Jun 30, 2026 | 565,985.00 |
| Mar 31, 2026 | 1.51 Mn |
| Dec 31, 2025 | 2.21 Mn |
| Sep 30, 2025 | 2.72 Mn |
| Jun 30, 2025 | 4.10 Mn |
| Mar 31, 2025 | 14,531.00 |
| Dec 31, 2024 | 79,568.00 |
| Sep 30, 2024 | 71,396.00 |
| Jun 30, 2024 | 924,596.00 |
| Mar 31, 2024 | 1,625.00 |
| Dec 31, 2023 | 1.29 Mn |
| Sep 30, 2023 | 153,332.00 |
| Jun 30, 2023 | 219,435.00 |
| Mar 31, 2023 | 138,491.00 |
| Dec 31, 2022 | 215,189.00 |
| Sep 30, 2022 | 158,323.00 |
| Jun 30, 2022 | 338,666.00 |
| Mar 31, 2022 | 482,175.00 |
| Dec 31, 2021 | 541,171.00 |
Protagenic Therapeutics, Inc.new Ending Cash Balance API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=PTIX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ending-cash-balance", "ticker": "PTIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=PTIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();